This is a routine employee warrant exercise with immaterial dilution. No market impact expected. Monitor upcoming quarterly results for operational updates.
GMAB drugs
GMAB drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 11 $53.87entry
- T+1 · 5d ago −3.95%α −3.60% · $51.74
- T+3 · todayOpen
- T+5 · tomorrow Pending
- T+20 · in 23d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Genmab issued 164,828 new shares via employee warrant exercises, raising approximately DKK 369.7 million (about 0.26% of share capital). The filing is a routine capital increase from employee equity plans, not a primary offering or dilutive event of material size.
Key Facts
- 164,828 new shares issued from employee warrant exercises
- Proceeds of approximately DKK 369.7 million
- Increase equals 0.2641% of Genmab's share capital
- Total share capital post-increase: DKK 62,570,683 (62,570,683 shares)
- Shares subscribed at prices ranging from DKK 1,362.5 to DKK 3,172 per share
Financial Impact
DKK 369.7 million (approximately $52 million) raised; dilution of 0.26% of outstanding shares
Risk Factors
- No material risks identified from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001434265-26-000148 |
| Document: gmab_20261110x6k.htm | 0001434265-26-000148 |
| Document: 0001434265-26-000148-index-headers.html | 0001434265-26-000148 |
| Document: 0001434265-26-000148-index.html | 0001434265-26-000148 |
| Document: 0001434265-26-000148.txt | 0001434265-26-000148 |
| Earnings Context (Synthetic; results releases only) | 0001434265-26-000148 |
Track record
31 reports on GMAB
3 of 5 bullish or bearish reports moved the stock their way by T+20. Best: +91.28% at T+60 after the Aug 6, 2026 report. 5 of 7 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $52.12 Now $51.57 −1.06% settles Dec 15
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $51.74 Now $51.57 −0.33% settles Dec 11
- Nov 10, 20266d ago 6-K Neutral 2/10 Viewing Entry $53.87 Now $51.57 −4.27% settles Dec 10
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $54.07 Now $51.57 −4.62% settles Dec 9
- Nov 5, 202611d ago 6-K Neutral 5/10 Entry $52.74 Now $51.57 −2.22% settles Dec 4
- Nov 4, 202612d ago Institutional Cluster Neutral 2/10 Entry $52.74 Now $51.57 −2.22% settles Dec 4
- Oct 28, 202619d ago 6-K Bullish 6/10 Entry $57.29 Now $51.57 −9.98% settles Nov 25
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers